SMAD1 and breast carcinoma: The observations in the breast cancer cell lines are in line with findings by Ren et al. 4 who showed that Dies1 silencing inhibited adipogenesis without altering the levels of BMP-pathway regulators such as phospho-Smad1, even in the presence of the BMP-receptor ligand, BMP44.